影响患者选择肾脏替代治疗模式的患者报告因素:欧洲多国调查
该研究调查了38个欧洲国家7820例终末期肾病患者,比较不同GDP国家在KRT模式选择信息提供、决策参与和体验上的差异。低GDP国家信息更晚、更少且满意度更低。多数决策由患者与肾科医生共同参与,HHD和肾移植体验更好。
要点
- 低GDP国家信息提供更晚、更少关于非CHD模式的信息且满意度更低。
- 多数模式决策由患者与肾科医生共同参与,HHD和肾移植体验更好。
核心结论
- 欧洲患者报告的KRT模式选择影响因素存在国家间差异,可能源于模式可及性、医疗体系和患者偏好不同。
- 应优化家庭透析和肾移植的可及性。
研究设计与样本
- 共纳入7820例患者,平均年龄59岁,56%男性,63%接受中心血液透析(CHD)。
- 按国家GDP分为低、中、高三组进行比较。
主要发现
- 42%患者未被告知家庭血液透析(HHD),33%未被告知综合保守管理。
- 高GDP国家护士更常提供信息,低GDP国家非肾科医生更常提供信息。
- 低GDP国家患者报告信息提供更晚、关于CHD以外模式的信息更少、对信息满意度更低。
- 多数模式决策由患者和肾科医生共同参与;患者报告主观(如生活质量和恐惧)和客观(如费用和治疗可及性)选择原因。
临床怎么用
- 肾科医生应提前(开始KRT前12个月以上)向患者提供所有KRT模式(包括HHD、腹膜透析、肾移植和综合保守管理)的信息。
- 决策时应让患者参与,并关注其主观(如生活质量、恐惧)和客观(如费用、可及性)因素。
- 应努力优化家庭透析和肾移植的可及性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Access to various kidney replacement therapy (KRT) modalities for patients with end-stage kidney disease differs substantially within Europe. METHODS: European adults on KRT filled out an online or paper-based survey about factors influencing and experiences with modality choice (e.g. information provision, decision-making and reasons for choice) between November 2017 and January 2019. We compared countries with low, middle and high gross domestic product (GDP). RESULTS: In total, 7820 patients [mean age 59 years, 56% male, 63% on centre haemodialysis (CHD)] from 38 countries participated. Twenty-five percent had received no information on the different modalities, and only 23% received information >12 months before KRT initiation. Patients were not informed about home haemodialysis (HHD) (42%) and comprehensive conservative management (33%). Besides nephrologists, nurses more frequently provided information in high-GDP countries, whereas physicians other than nephrologists did so in low-GDP countries. Patients from low-GDP countries reported later information provision, less information about other modalities than CHD and lower satisfaction with information. The majority of modality decisions were made involving both patient and nephrologist. Patients reported subjective (e.g. quality of life and fears) and objective reasons (e.g. costs and availability of treatments) for modality choice. Patients had good experiences with all modalities, but experiences were better for HHD and kidney transplantation and in middle- and high-GDP countries. CONCLUSION: Our results suggest European differences in patient-reported factors influencing KRT modality choice, possibly caused by disparities in availability of KRT modalities, different healthcare systems and varying patient preferences. Availability of home dialysis and kidney transplantation should be optimized.
引用
- de Jong RW, Stel VS, Rahmel A, et al. Patient-reported factors influencing the choice of their kidney replacement treatment modality. Nephrol Dial Transplant. 2022. PMID: 33677544. doi:10.1093/ndt/gfab059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。